Trial · NCT05568888
Adverse events362
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 362
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Deep vein thrombosis | Vascular disorders | BE1116 | 32 | 618 | 41 |
| other | Deep vein thrombosis | Vascular disorders | Placebo | 39 | 627 | 44 |
| serious | Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | BE1116 | 42 | 618 | 44 |
| serious | Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | Placebo | 48 | 627 | 50 |
| serious | Acute respiratory distress syndrome | Respiratory, thoracic and mediastinal disorders | BE1116 | 18 | 618 | 18 |
| serious | Acute respiratory distress syndrome | Respiratory, thoracic and mediastinal disorders | Placebo | 21 | 627 | 21 |
| serious | Respiratory failure | Respiratory, thoracic and mediastinal disorders | BE1116 | 10 | 618 | 10 |
| serious | Respiratory failure | Respiratory, thoracic and mediastinal disorders | Placebo | 5 | 627 | 5 |
| serious | Acute Respiratory failure | Respiratory, thoracic and mediastinal disorders | BE1116 | 7 | 618 | 7 |
| serious | Acute Respiratory failure | Respiratory, thoracic and mediastinal disorders | Placebo | 4 | 627 | 4 |
| serious | Pneumothorax | Respiratory, thoracic and mediastinal disorders | BE1116 | 6 | 618 | 6 |
| serious | Pneumothorax | Respiratory, thoracic and mediastinal disorders | Placebo | 6 | 627 | 6 |
| serious | Pleural effusion | Respiratory, thoracic and mediastinal disorders | BE1116 | 4 | 618 | 4 |
| serious | Pleural effusion | Respiratory, thoracic and mediastinal disorders | Placebo | 2 | 627 | 2 |
| serious | Respiratory distress | Respiratory, thoracic and mediastinal disorders | BE1116 | 3 | 618 | 3 |
| serious | Respiratory distress | Respiratory, thoracic and mediastinal disorders | Placebo | 1 | 627 | 1 |
| serious | Haemothorax | Respiratory, thoracic and mediastinal disorders | BE1116 | 2 | 618 | 2 |
| serious | Haemothorax | Respiratory, thoracic and mediastinal disorders | Placebo | 0 | 627 | 0 |
| serious | Bronchial secretion retention | Respiratory, thoracic and mediastinal disorders | BE1116 | 1 | 618 | 1 |
| serious | Bronchial secretion retention | Respiratory, thoracic and mediastinal disorders | Placebo | 0 | 627 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05568888/events